Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

Stefano Omboni, Claudio Borghi, Ambrosioni, Cicero, Stefano Bacchelli, Daniela Degli Esposti, Novo, Dragos Vinereanu, Giuseppe Ambrosio, Reggiardo, Zava
  • ClinicoEconomics and Outcomes Research, July 2013, Dove Medical Press
  • DOI: 10.2147/ceor.s43138

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Prof. Stefano Omboni, Dr Arrigo FG CICERO, and Professor Giuseppe Ambrosio